PA
HCAT icon

Perceptive Advisors’s Health Catalyst HCAT Stock Holding History

Perceptive Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-389,962
Closed -$3.78M – 103
2022
Q3 		$3.78M Sell
389,962
-75,200
-16% -$996K 0.11% 90
2022
Q2 		$6.74M Sell
465,162
-28,500
-6% -$486K 0.21% 74
2022
Q1 		$12.9M Buy
493,662
+39,658
+9% +$1.13M 0.26% 72
2021
Q4 		$18M Sell
454,004
-135,000
-23% -$6.15M 0.28% 72
2021
Q3 		$29.5M Buy
589,004
+22,920
+4% +$1.25M 0.43% 58
2021
Q2 		$31.4M Buy
566,084
+60,000
+12% +$3.2M 0.41% 55
2021
Q1 		$23.7M Buy
506,084
+230,000
+83% +$11.1M 0.3% 72
2020
Q4 		$12M Sell
276,084
-15,000
-5% -$553K 0.13% 103
2020
Q3 		$10.7M Sell
291,084
-44,698
-13% -$1.52M 0.16% 85
2020
Q2 		$9.79M Buy
335,782
+7,084
+2% +$196K 0.16% 81
2020
Q1 		$8.38M Buy
328,698
+45,000
+16% +$1.37M 0.22% 65
2019
Q4 		$9.84M Buy
283,698
+72,774
+35% +$2.41M 0.2% 66
2019
Q3 		$6.67M Buy
+210,924
New +$8.3M 0.18% 67

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Perceptive Advisors's HCAT Position: Q4 2022 in Review

Perceptive Advisors sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 389,962 shares — an estimated $3.78M sold.

Perceptive Advisors first reported a position in HCAT in Q3 2019 and held it in 13 quarters. The position peaked at $31.4M in Q2 2021. 166 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.

  • Perceptive Advisors reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
  • Perceptive Advisors sold 389,962 Health Catalyst shares in Q4 2022, an estimated $3.78M.
  • Perceptive Advisors first reported a position in Health Catalyst in Q3 2019 and held it in 13 quarters.
  • Perceptive Advisors's Health Catalyst position peaked at $31.4M in Q2 2021.
  • 166 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.

Based on Perceptive Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.